Yi X. Cen

Guangzhou Medical University Guangdong Provincial Key Laboratory Of Molecular Target & Clinical Pharmacology, The NMPA And State Key Laboratory Of Respiratory Disease
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Experiences of young adults with cardiovascular disease in using digital health: a protocol for a qualitative systematic review and meta-synthesis from the perspective of media affordances.

Experiences of young adults with cardiovascular disease in using digital health: a protocol for a qualitative systematic review and meta-synthesis from the perspective of media affordances.

Journal: Frontiers in cardiovascular medicine

Published: February 07, 2026

Nano-co-delivery Systems Combining Chemical and Photodynamic Therapy against Breast Cancer.

Nano-co-delivery Systems Combining Chemical and Photodynamic Therapy against Breast Cancer.

Journal: Current drug delivery

Published: November 10, 2025

Self-promoted tumor-targeting nanomedicine activates STING-driven antitumor immunity via photodynamic DNA damage and PARP inhibition.

Self-promoted tumor-targeting nanomedicine activates STING-driven antitumor immunity via photodynamic DNA damage and PARP inhibition.

Journal: Chemical science

Published: March 12, 2025

Self-Promoting Targeted Delivery of Epigenetic Immunostimulants to Activate Breast Cancer Immunity via HDACs Downregulation and PD-L1 Upregulation.

Self-Promoting Targeted Delivery of Epigenetic Immunostimulants to Activate Breast Cancer Immunity via HDACs Downregulation and PD-L1 Upregulation.

Journal: Angewandte Chemie (International ed. in English)

Published: January 24, 2025

Chimeric Peptide-Engineered Polyprodrug Enhances Cytotoxic T Cell Response by Inducing Immunogenic Cell Death and Upregulating Major Histocompatibility Complex Class I.

Chimeric Peptide-Engineered Polyprodrug Enhances Cytotoxic T Cell Response by Inducing Immunogenic Cell Death and Upregulating Major Histocompatibility Complex Class I.

Journal: ACS nano

Published: December 28, 2024

Plasma Membrane Targeted Photodynamic Nanoagonist to Potentiate Immune Checkpoint Blockade Therapy by Initiating Tumor Cell Pyroptosis and Depleting Infiltrating B Cells.

Plasma Membrane Targeted Photodynamic Nanoagonist to Potentiate Immune Checkpoint Blockade Therapy by Initiating Tumor Cell Pyroptosis and Depleting Infiltrating B Cells.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: October 03, 2024

AR expression-independent XRCC3 mediates DNA damage-induced p53/Bax signaling pathway activation against prostate cancer.

AR expression-independent XRCC3 mediates DNA damage-induced p53/Bax signaling pathway activation against prostate cancer.

Journal: Journal of cancer research and clinical oncology

Published: July 14, 2024

miR-455-3p has superior diagnostic potential to PSA in peripheral blood for prostate cancer.

miR-455-3p has superior diagnostic potential to PSA in peripheral blood for prostate cancer.

Journal: PloS one

Published: April 23, 2024

Nodularin-R Synergistically Enhances Abiraterone Against Castrate- Resistant Prostate Cancer via PPP1CA Inhibition.

Nodularin-R Synergistically Enhances Abiraterone Against Castrate- Resistant Prostate Cancer via PPP1CA Inhibition.

Journal: Journal of cellular and molecular medicine

Published: April 09, 2024

Transferrin receptor-targeted immunostimulant for photodynamic immunotherapy against metastatic tumors through β-catenin/CREB interruption.

Transferrin receptor-targeted immunostimulant for photodynamic immunotherapy against metastatic tumors through β-catenin/CREB interruption.

Journal: Acta pharmaceutica Sinica. B

Published: January 10, 2024

Self-Assembled PD-L1 Downregulator to Boost Photodynamic Activated Tumor Immunotherapy Through CDK5 Inhibition.

Self-Assembled PD-L1 Downregulator to Boost Photodynamic Activated Tumor Immunotherapy Through CDK5 Inhibition.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: December 11, 2023

LINC00634 is a novel prognostic biomarker for colon cancer associated with immune infiltration.

LINC00634 is a novel prognostic biomarker for colon cancer associated with immune infiltration.

Journal: BMC gastroenterology

Published: November 23, 2023

Showing 1-12 of 22

Last Updated: 09/26/2026